At this stage Non-Small Cell Lung Cancer who can not accept surgical treatment, there are a very effective treatment options. Doctors said the choice of radical stereotactic radiosurgery with the Cyberknife treatment, patients treated more than three years for good lung power and 100% survival.
"Our goal is to find a patient is unwilling or unable to be operative according to the rational choice," head of the study, said Dr. Brian Collins t Lombardi Comprehensive Cancer Center radiation oncologist at Georgetown University Hospital . "What we found is a very promising option that may be relevant to other phases of a patient. More to follow up these patients from the plan to see how they are 5 years after treatment, the progress made."
An average follow-up of 36 months, overall survival for all patients was 79 in the 5 lung function decline as a result of death. The use of FEV1 in patients with a better survival rate 100%.
The study was conducted by the digital navigation tool will be. Collins reports received from accuray, digital navigation tool for clinical consulting firm for compensation. Anderson has received honoraria accuray education.
- More Common in Public Hospitals:Delays in Lung Cancer Care
- There is a risk, prophylactic cranial radiation therapy in patients with lung cancer
- A new method of treatment for lung cancer
- The researchers focus on joint development of mesothelioma drug
- Hispanic Americans are not easy to Cancer